Repurposing of Doramectin as a New Anti-Zika Virus Agent
Zika virus (ZIKV), belonging to the <i>Flavivirus</i> family and mainly transmitted by mosquitoes, causes a variety of adverse outcomes, including Guillain-Barré syndrome, microcephaly, and meningoencephalitis. However, there are no approved vaccines or drugs available for ZIKV. The disc...
Main Authors: | Yujia Zhu, Minqi Liang, Jianchen Yu, Bingzhi Zhang, Ge Zhu, Yun Huang, Zhenjian He, Jie Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/5/1068 |
Similar Items
-
A Marine Natural Product, Harzianopyridone, as an Anti-ZIKV Agent by Targeting RNA-Dependent RNA Polymerase
by: Kexin Zhang, et al.
Published: (2024-02-01) -
Dapoxetine, a Selective Serotonin Reuptake Inhibitor, Suppresses Zika Virus Infection In Vitro
by: Bingzhi Zhang, et al.
Published: (2023-12-01) -
Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
by: Jie Yuan, et al.
Published: (2020-07-01) -
Identification of 6ω-cyclohexyl-2-(phenylamino carbonylmethylthio)pyrimidin-4(3H)-ones targeting the ZIKV NS5 RNA dependent RNA polymerase
by: Guang-Feng Zhou, et al.
Published: (2022-10-01) -
Chikungunya virus nsP4 RNA-dependent RNA polymerase core domain displays detergent-sensitive primer extension and terminal adenylyltransferase activities
by: Chen, Ming Wei, et al.
Published: (2017)